A Phase I/II, Randomised, Placebo-controlled, Partially-blinded, Parallel-group Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose FLU
Phase of Trial: Phase I/II
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Eurocine
- 05 Oct 2017 Status changed from active, no longer recruiting to completed.
- 07 Apr 2017 According to Eurocine media release, results are expected in June/July 2017.
- 10 Nov 2016 Status changed from recruiting to active, no longer recruiting.